Evidence-based suggestions on the management of severe VHD in active cancer patients are provided, focusing on risk stratification of VHD in cancer patients, including the impact of chemotherapies, targeted therapies and non-cardiac surgery.
J. Ternacle, M. Mirabel, C. Diakov et al.· European Heart Journal· 0 citations
TTVR with the LuX-Valve Plus system to treat patients with severe or greater symptomatic TR and a large tricuspid annulus was associated with high intraprocedural and 30-day clinical success rates, significant TR reduction and functional improvement, and low permanent pacemaker implantation rates.
O. de Backer, Y. Lim, R. von Bardeleben et al.· EuroIntervention· 0 citations
The TVARC and ASE cutoffs for RV dysfunction showed prognostic value in patients with significant STR, and combining TAPSE and RVFWLS may provide a pragmatic, exploratory framework for risk stratification of these patients.
X. Galloo, M. Dietz, E. Prihadi et al.· JACC Cardiovascular Imaging· 1 citation
A practical framework for the perioperative use of myocardial strain is provided by summarizing the current evidence, clarifying its methodological limitations, simplifying its acquisition and interpretation for non-expert users, distinguishing established clinical applications from future research directions, and iden...
C. Beyls, F. Gonzalez, E. Donal et al.· Journal of Clinical Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
